| Literature DB >> 24688675 |
Amornpan Klanchui1, Tayvich Vorapreeda2, Wanwipa Vongsangnak3, Chiraphan Khannapho2, Supapon Cheevadhanarak4, Asawin Meechai5.
Abstract
Arthrospira are attractive candidates to serve as cell factories for production of many valuable compounds useful for food, feed, fuel and pharmaceutical industries. In connection with the development of sustainable bioprocessing, it is a challenge to design and develop efficient Arthrospira cell factories which can certify effective conversion from the raw materials (i.e. CO2 and sun light) into desired products. With the current availability of the genome sequences and metabolic models of Arthrospira, the development of Arthrospira factories can now be accelerated by means of systems biology and the metabolic engineering approach. Here, we review recent research involving the use of Arthrospira cell factories for industrial applications, as well as the exploitation of systems biology and the metabolic engineering approach for studying Arthrospira. The current status of genomics and proteomics through the development of the genome-scale metabolic model of Arthrospira, as well as the use of mathematical modeling to simulate the phenotypes resulting from the different metabolic engineering strategies are discussed. At the end, the perspective and future direction on Arthrospira cell factories for industrial biotechnology are presented.Entities:
Year: 2012 PMID: 24688675 PMCID: PMC3962090 DOI: 10.5936/csbj.201210015
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Figure 1An integration of systems biology with metabolic engineering for advancing industrial biotechnology in order to develop efficient cell factories of Arthrospira.
Summary of different strains of Arthrospira's potential substances for industrial biotechnology applications.
| Biotechnological importance | References | ||
|---|---|---|---|
|
| |||
| Potential products | Industries | ||
| Food supplement | Dietary supplements | [ | |
| Feed additive | Aquacultures and animal feeds | [ | |
| Vitamin B12 | Pharmaceuticals | [ | |
| Carotenoids | Pharmaceuticals | [ | |
| Tocopherols | Pharmaceuticals | [ | |
| Phenolic acids | Pharmaceuticals | [ | |
| Selenium | Pharmaceuticals | [ | |
| Enzymatic antioxidants | Pharmaceuticals | [ | |
| GLA | Pharmaceuticals | [ | |
| Calcium spirulan | Pharmaceuticals | [ | |
| Polysaccharides | Pharmaceuticals | [ | |
| Phycocyanin | Pharmaceuticals | [ | |
| Biodiesel | Biofuels | [ | |
| H2 | Biofuels | [ | |
Figure 2Schematic pathway diagram of the Arthrospira core metabolic process for the production of the chemical building blocks used as the precursors of high-value compounds discussed in this review. Abbreviations are: ADPG, ADP-glucose; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; FBP, fructose 1, 6-bisphosphate; GAP, glyceraldehyde phosphate; DHAP, dihydroxyacetone phosphate; 3PG, 1,3-bisphosphoglycerate; Pyr, pyruvate; AcCoA, acetyl-CoA; FD, hydrogenase-ferredoxin; PS I, photosystem I; PS II, photosystem II.
Summary of genomics information of Arthrospira strains.
| Strains | Genome sizes (Mb) | Genes | No. of contigs | No. of scaffolds | NCBI Project IDs |
|---|---|---|---|---|---|
|
| 6.00 | 5,73 | 129 | 129 | 29085 |
|
| 4.99 | 5,401 | 1,82 | 1,82 | 34793 |
|
| 6.14 | 5,718 | 119 | 16 | 40633 |
|
| 6.78 | 6,676 | 18 | 1 | 42161 |
|
| 6.08 | 6,153 | 63 | 1 | 67617 |
Figure 3A schematic diagram of the development and applications of the first genome-scale model of Arthrospira, iAK692.
Figure 4Development of metabolic models of A. platensis. Each box represents a summary of a name and scope of a metabolic model. The number of metabolites (blue bar), reactions (red bar), and genes (green bar) are shown.